| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma
|
Naito, Seiji
|
|
2010
|
66 |
6 |
p. 1065-1070
|
artikel
|
| 2 |
A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol
|
Dickson, Mark A.
|
|
2010
|
66 |
6 |
p. 1113-1121
|
artikel
|
| 3 |
A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer
|
Ko, Andrew H.
|
|
2010
|
66 |
6 |
p. 1051-1057
|
artikel
|
| 4 |
A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies
|
Paik, Paul K.
|
|
2010
|
66 |
6 |
p. 1079-1085
|
artikel
|
| 5 |
Bendamustine pharmacokinetic profile and exposure–response relationships in patients with indolent non-Hodgkin’s lymphoma
|
Owen, Joel S.
|
|
2010
|
66 |
6 |
p. 1039-1049
|
artikel
|
| 6 |
Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study
|
Tanaka, Yoshihiro
|
|
2010
|
66 |
6 |
p. 1159-1165
|
artikel
|
| 7 |
Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93)
|
Rathore, Ritesh
|
|
2010
|
66 |
6 |
p. 1013-1017
|
artikel
|
| 8 |
Development of a modeling framework to simulate efficacy endpoints for motesanib in patients with thyroid cancer
|
Claret, Laurent
|
|
2010
|
66 |
6 |
p. 1141-1149
|
artikel
|
| 9 |
Hepatotoxicity of intra-arterial combination chemotherapy in patients with liver cirrhosis and advanced hepatocellular carcinoma
|
Nagai, Hidenari
|
|
2010
|
66 |
6 |
p. 1123-1129
|
artikel
|
| 10 |
Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma
|
Mir, Olivier
|
|
2010
|
66 |
6 |
p. 1059-1063
|
artikel
|
| 11 |
Inhibition of established subcutaneous murine tumour growth with topical Melaleuca alternifolia (tea tree) oil
|
Greay, Sara J.
|
|
2010
|
66 |
6 |
p. 1095-1102
|
artikel
|
| 12 |
Optimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancer
|
Egerton, Nancy
|
|
2010
|
66 |
6 |
p. 1005-1012
|
artikel
|
| 13 |
Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?
|
Mamidi, Rao N. V. S.
|
|
2010
|
66 |
6 |
p. 1173-1184
|
artikel
|
| 14 |
Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement
|
Tsimberidou, Apostolia M.
|
|
2010
|
66 |
6 |
p. 1087-1093
|
artikel
|
| 15 |
Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer
|
Lam, Elaine T.
|
|
2010
|
66 |
6 |
p. 1019-1029
|
artikel
|
| 16 |
Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer
|
Lam, Elaine T.
|
|
|
66 |
6 |
p. 1019-1029
|
artikel
|
| 17 |
Population pharmacokinetic/pharmacodynamic modeling for the time course of tumor shrinkage by motesanib in thyroid cancer patients
|
Lu, Jian-Feng
|
|
2010
|
66 |
6 |
p. 1151-1158
|
artikel
|
| 18 |
Resistance to platinum-based chemotherapy in lung cancer cell lines
|
Chen, Jianli
|
|
2010
|
66 |
6 |
p. 1103-1111
|
artikel
|
| 19 |
Sonodynamically induced apoptosis and active oxygen generation by gallium–porphyrin complex, ATX-70
|
Yumita, Nagahiko
|
|
2010
|
66 |
6 |
p. 1071-1078
|
artikel
|
| 20 |
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer
|
Shi, Yi-kang
|
|
2010
|
66 |
6 |
p. 1131-1140
|
artikel
|
| 21 |
Value of gene polymorphisms as markers of 5-FU therapy response in stage III colon carcinoma: a pilot study
|
Fariña-Sarasqueta, Arantza
|
|
2010
|
66 |
6 |
p. 1167-1171
|
artikel
|
| 22 |
Zonula Occludens-1 alterations and enhanced intestinal permeability in methotrexate-treated rats
|
Hamada, Kazuma
|
|
2010
|
66 |
6 |
p. 1031-1038
|
artikel
|
Tijdschrift beschrijving